Validation of heart failure quality of life tool and usage to predict all-cause mortality in acute heart failure in Uganda: the Mbarara heart failure registry (MAHFER)
- PMID: 30541443
- PMCID: PMC6291962
- DOI: 10.1186/s12872-018-0959-1
Validation of heart failure quality of life tool and usage to predict all-cause mortality in acute heart failure in Uganda: the Mbarara heart failure registry (MAHFER)
Abstract
Background: The health-related quality of life (HRQoL) is an important treatment goal that could serve as low-cost prognostication tool in resource poor settings. We sought to validate the Kansas City Cardiomyopathy Questionnaire (KCCQ) and evaluate its use as a predictor of 3 months all-cause mortality among heart failure participants in rural Uganda.
Methods: The Mbarara Heart Failure Registry Cohort study observes heart failure patients during hospital stay and in the community in rural Uganda. Participants completed health failure evaluations and HRQoL questionnaires at enrollment, 1 and 3 months of follow-up. We used Cronbach's alpha coefficients to define internal consistency, intraclass correlation coefficients as a reliability coefficient, and Cox proportional hazard models to predict the risk of 3 months all-cause mortality.
Results: Among the 195 participants who completed HRQoL questionnaires, the mean age was 52 (standard deviation (SD) 21.4) years, 68% were women and 29% reported history of hypertension. The KCCQ had excellent internal consistency (87% Cronbach alpha) but poor reliability. Independent predictors of all-cause mortality within 3 months included: worse overall KCCQ score (Adjusted Hazard ratio (AHR) 2.9, 95% confidence interval (CI) 1.1, 8.1), highest asset ownership (AHR 3.6, 95% CI 1.2, 10.8), alcoholic drinks per sitting (AHR per 1 drink 1.4, 95% CI 1.0, 1.9), New York Heart Association (NYHA) functional class IV heart failure (AHR 2.6, 95% CI 1.3, 5.4), estimated glomerular filtration rate (eGFR) 30 to 59 ml/min/1.73 m2 (AHR 3.4, 95% CI 1.1, 10.8), and eGFR less than 15 ml/min/1.73 m2 (AHR 2.7, 95% CI 1.0, 7.1), each 1 pg/mL increase in Brain Natriuretic Peptide (BNP) (AHR, 1.0, 95% CI 1.0, 1.0), and each 1 ng/mL increase in Creatine-Kinase MB isomer (CKMB) (AHR 1.0, 95% CI 1.0, 1.1).
Conclusion: The KCCQ showed excellent internal consistency. Worse overall KCCQ score, highest asset ownership, increasing alcoholic drink per sitting, NYHA class IV, decreased estimated glomerular filtration rate, BNP, and CKMB predicted all-cause mortality at 3 months. The KCCQ could be an additional low-cost tool to aid in the prognostication of acute heart failure patients.
Keywords: 36-item short form health survey; Acute heart failure; All-cause mortality; Kansas City cardiomyopathy questionnaire; Sub-Saharan Africa.
Conflict of interest statement
Ethics approval and consent to participate
The ethical review boards at the Mbarara University of Science and Technology (number: 26/11–14), the University of Virginia Health System, and the Uganda National Council of Science and Technology (number: HS2024) approved the conduct of this study. All participants signed a written informed consent prior to study participation.
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Similar articles
-
Adapting and usability testing of the Kansas city cardiomyopathy questionnaire (KCCQ) in a heart failure clinic in Tanzania: the Swahili KCCQ.BMC Cardiovasc Disord. 2023 May 6;23(1):242. doi: 10.1186/s12872-023-03265-0. BMC Cardiovasc Disord. 2023. PMID: 37149565 Free PMC article.
-
Incidence and predictors of 6 months mortality after an acute heart failure event in rural Uganda: The Mbarara Heart Failure Registry (MAHFER).Int J Cardiol. 2018 Aug 1;264:113-117. doi: 10.1016/j.ijcard.2018.03.110. Epub 2018 Mar 29. Int J Cardiol. 2018. PMID: 29655949 Free PMC article.
-
Psychometric properties of the Japanese version of the Kansas City Cardiomyopathy Questionnaire in Japanese patients with chronic heart failure.Health Qual Life Outcomes. 2020 Jul 17;18(1):236. doi: 10.1186/s12955-020-01483-0. Health Qual Life Outcomes. 2020. PMID: 32680513 Free PMC article.
-
Predictive value of quality of life as measured by KCCQ in heart failure patients: A meta-analysis.Eur J Clin Invest. 2024 Sep;54(9):e14233. doi: 10.1111/eci.14233. Epub 2024 Apr 26. Eur J Clin Invest. 2024. PMID: 38666585
-
Association Between Disease-specific Health-related Quality of Life and All-cause Mortality in Patients with Heart Failure: A Meta-analysis.Curr Probl Cardiol. 2023 Apr;48(4):101592. doi: 10.1016/j.cpcardiol.2023.101592. Epub 2023 Jan 8. Curr Probl Cardiol. 2023. PMID: 36632931 Review.
Cited by
-
Establishment of a cardiac telehealth program to support cardiovascular diagnosis and care in a remote, resource-poor setting in Uganda.PLoS One. 2021 Aug 6;16(8):e0255918. doi: 10.1371/journal.pone.0255918. eCollection 2021. PLoS One. 2021. PMID: 34358281 Free PMC article.
-
Risk Factors and Prevalence of Dilated Cardiomyopathy in Sub-Saharan Africa: A Systematic Review.Glob Heart. 2022 Oct 21;17(1):76. doi: 10.5334/gh.1166. eCollection 2022. Glob Heart. 2022. PMID: 36382153 Free PMC article.
-
Individual Trajectories of Health Status During the First Year of Discharge From Hospitalization for Heart Failure and Their Associations With Death in the Following Years.J Am Heart Assoc. 2023 Jul 18;12(14):e028782. doi: 10.1161/JAHA.122.028782. Epub 2023 Jul 8. J Am Heart Assoc. 2023. PMID: 37421271 Free PMC article. Clinical Trial.
-
Adapting and usability testing of the Kansas city cardiomyopathy questionnaire (KCCQ) in a heart failure clinic in Tanzania: the Swahili KCCQ.BMC Cardiovasc Disord. 2023 May 6;23(1):242. doi: 10.1186/s12872-023-03265-0. BMC Cardiovasc Disord. 2023. PMID: 37149565 Free PMC article.
-
Impact of Technologic Innovation and COVID-19 Pandemic on Pediatric Cardiology Telehealth.Curr Treat Options Pediatr. 2022;8(4):309-324. doi: 10.1007/s40746-022-00258-7. Epub 2022 Sep 22. Curr Treat Options Pediatr. 2022. PMID: 36479525 Free PMC article. Review.
References
-
- Gwaltney C, Tiplady B, Deschaseaux C. Using the clinical summary score from the Kansas City cardiomyopathy questionnaire as an endpoint in clinical trials: psychometric support. Value Health. 2015;18(3):A24. doi: 10.1016/j.jval.2015.03.147. - DOI
-
- Sydor B, Spertus J. Linguistic validation and electronic migration of the Kansas City cardiomyopathy questionnaire (KCCQ) Value Health. 2016;19(7):A391. doi: 10.1016/j.jval.2016.09.253. - DOI
-
- Hawwa N, Vest AR, Kumar R, Lahoud R, Young JB, Wu Y, Gorodeski EZ, Cho L. Comparison between the Kansas City cardiomyopathy questionnaire and New York heart association in assessing functional capacity and clinical outcomes. J Card Fail. 2017;23(4):280–285. doi: 10.1016/j.cardfail.2016.12.002. - DOI - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous